{
    "id": "dbpedia_563_2",
    "rank": 41,
    "data": {
        "url": "https://www.avalonhcs.com/who-we-are/",
        "read_more_link": "",
        "language": "en",
        "title": "Who We Are – Avalon Healthcare Solutions",
        "top_image": "https://www.avalonhcs.com/wp-content/uploads/2021/05/cropped-Social_RGB-01-1-32x32.png",
        "meta_img": "https://www.avalonhcs.com/wp-content/uploads/2021/05/cropped-Social_RGB-01-1-32x32.png",
        "images": [
            "https://www.avalonhcs.com/wp-content/uploads/2021/05/avalon_color_logo-195x50.png",
            "https://www.avalonhcs.com/wp-content/uploads/2021/05/avalon_color_logo-195x50.png",
            "https://www.avalonhcs.com/wp-content/uploads/2022/09/Bill-scaled-e1662053792443.jpg",
            "https://www.avalonhcs.com/wp-content/uploads/2024/07/Chris-Carlson-headshot-1-e1720643164217.png",
            "https://www.avalonhcs.com/wp-content/uploads/2022/09/Barry-scaled-e1662054418549.jpg",
            "https://www.avalonhcs.com/wp-content/uploads/2022/09/John-scaled-e1691172550770.jpg",
            "https://www.avalonhcs.com/wp-content/uploads/2023/08/Lynn-Mettler-scaled-e1691173856643.jpg",
            "https://www.avalonhcs.com/wp-content/uploads/2022/09/Steve-scaled-e1691174303500.jpg",
            "https://www.avalonhcs.com/wp-content/uploads/2023/08/Jason-Bush-scaled-e1691173808725.jpg",
            "https://www.avalonhcs.com/wp-content/uploads/2023/08/Mike-Snyder-scaled-e1691172748938.jpg",
            "https://www.avalonhcs.com/wp-content/uploads/2024/05/Derek-Anderson-e1715886679687.jpg",
            "https://www.avalonhcs.com/wp-content/uploads/2023/08/Michele-Norton-scaled-e1691172893381.jpg",
            "https://www.avalonhcs.com/wp-content/uploads/2022/09/Wendy-scaled-e1691172541225.jpg",
            "https://www.avalonhcs.com/wp-content/uploads/2021/06/GEOFF_BAIRD.jpeg",
            "https://www.avalonhcs.com/wp-content/uploads/2021/06/Tim-Hamill-768x768.jpeg",
            "https://www.avalonhcs.com/wp-content/uploads/2022/09/Jane-Strandberg-Gibson-Headshot-e1663868604932-768x768.png",
            "https://www.avalonhcs.com/wp-content/uploads/2021/06/BRIAN-RUBIN-768x768.jpeg",
            "https://www.avalonhcs.com/wp-content/uploads/2021/06/BRIAN-SMITH-768x768.jpg",
            "https://www.avalonhcs.com/wp-content/uploads/2021/06/Ezra_Perlman-768x768.jpeg",
            "https://www.avalonhcs.com/wp-content/uploads/2021/06/Lauren-Macklis.jpeg",
            "https://www.avalonhcs.com/wp-content/uploads/2022/09/Bill-scaled-e1662053792443-768x768.jpg",
            "https://www.avalonhcs.com/wp-content/uploads/2021/06/STEPHANY-VERSTRAETE-768x768.jpg",
            "https://www.avalonhcs.com/wp-content/uploads/2021/06/DUNCAN-JAMES-768x768.jpg",
            "https://www.avalonhcs.com/wp-content/uploads/2021/06/JESSICA-ZEASKE--768x768.jpg",
            "https://www.avalonhcs.com/wp-content/uploads/2021/06/Andy_Folsom.jpeg",
            "https://www.avalonhcs.com/wp-content/uploads/2021/06/HOLLY-BENSON-768x768.jpg",
            "https://www.avalonhcs.com/wp-content/uploads/2022/07/ncqa-logo-400x366-1365635102.png",
            "https://www.avalonhcs.com/wp-content/uploads/2022/07/hitrust_rev.png",
            "https://www.avalonhcs.com/wp-content/uploads/2023/04/2023_tbt_top_workPlace_accolade_600x600.png",
            "https://www.avalonhcs.com/wp-content/uploads/2023/02/2023-Top-Workplaces-USA-Badge-622-x-1023.png",
            "https://www.avalonhcs.com/wp-content/uploads/2022/05/Copy-of-TWP-Avalon-Healthcare-Multi-2020-2022@2x.png",
            "https://www.avalonhcs.com/wp-content/uploads/2022/05/Copy-of-TWP-USA-2022@2x.png",
            "https://www.avalonhcs.com/wp-content/uploads/2022/07/TopPlacesGraphics.png",
            "https://www.avalonhcs.com/wp-content/uploads/2022/05/innovation-1.png",
            "https://www.avalonhcs.com/wp-content/uploads/2022/05/work_life.png",
            "https://www.avalonhcs.com/wp-content/uploads/2022/05/purpose.png",
            "https://www.avalonhcs.com/wp-content/uploads/2022/05/leadership-1.png",
            "https://www.avalonhcs.com/wp-content/uploads/2023/05/2023_BPTW_Badge-1024x1004.png",
            "https://www.avalonhcs.com/wp-content/uploads/2023/02/2023_TTT-Best-Tech-Startups-1084-x-793-1024x749.png",
            "https://www.avalonhcs.com/wp-content/uploads/2023/02/2023_HTR-Power-500-702-x-347.png",
            "https://www.avalonhcs.com/wp-content/uploads/2022/08/Copy-of-HTR-Top-100-2022-1024x906.png",
            "https://www.avalonhcs.com/wp-content/uploads/2022/07/Avalon_HCS_Inc500_2020-94238247-1024x749.png",
            "https://www.avalonhcs.com/wp-content/uploads/2021/05/avalon_logo-300x77.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "https://www.avalonhcs.com/wp-content/uploads/2021/05/cropped-Social_RGB-01-1-32x32.png",
        "meta_site_name": "",
        "canonical_link": "https://www.avalonhcs.com/who-we-are/",
        "text": "Good clinical decision-making requires ordering the right test at the right time from the right provider. With the science of laboratory testing exploding, Dr. Kerr is pleased to be a part of the Avalon team’s ability to scale laboratory science into the healthcare ecosystem.\n\nBefore cofounding Avalon, Dr. Kerr was the Chief Medical and Growth Officer at CareCentrix, a company focused on health in the home. Prior to CareCentrix, Dr. Kerr was the Chief Medical Officer at WellCare Health Plans and Blue Cross Blue Shield of Florida. Dr. Kerr was previously Vice President of Professional Networks at Independence Blue Cross and regional medical director for a number of plans in Texas.\n\nDr. Kerr holds a BA from the University of Arkansas, an MBA from the University of Houston, an MD from the University of Arkansas. He was also a research associate in the Nuffield department of pathology at the University of Oxford.\n\nChris has 20+ years of healthcare operations experience focusing on operational excellence while serving in leadership roles spanning clinical, product, innovation, digital, benefit, and service organizations. Prior to joining Avalon, Chris served as the Senior Vice President of Provider Digital Transformation at UnitedHealthcare. In that role, he led and operated the design, development, and execution of all healthcare provider digital, data, and service capabilities for UnitedHealthcare.\n\nBefore leading the Provider Digital team, Chris completed rotations in the UnitedHealth Group Consumer Innovation organization, Commercial Markets Product leadership, Benefit Operations, and Clinical Operations teams. During this time, Chris was fortunate to have an opportunity to focus on developing and delivering comprehensive solutions for families with children with a particular healthcare need, advancing solutions for patients with rare diseases, and members struggling with complex medical conditions. Earlier in his healthcare journey, Chris served in various operational leadership roles spanning the benefit operations of the world’s largest health insurer.\n\nChris has a B.S. in Genetics and Cell Biology from the University of Minnesota and an MBA from the Carlson School of Management at the University of Minnesota. He currently serves on the St. Jude Children’s Research Hospital—ALSAC Advisory Council in Minneapolis.\n\nIn his role as Chief Growth Officer at Avalon Healthcare Solutions, Barry Davis is responsible for growing the company’s revenues and services through a national business development strategy.\n\nBarry possesses 30 years of healthcare experience working with and servicing health plans. Prior to joining Avalon in 2017, he was Sr. Vice President of the Health Plan Segment at OptumRx, the Pharmacy Benefit Management division of UnitedHealth Group. In that capacity, Barry led a cross-functional team managing a multi-billion dollar business.\n\nBarry is a former member of the executive team for Chicago’s CatamaranRx. He also spent nearly 20 years in various sales, service, and operations roles at Medco Health Solutions (now part of Express Scripts).\n\nBarry holds a BSBA from Bucknell University.\n\nAs Chief Financial Officer of Avalon Healthcare Solutions, John Adams is responsible for the company’s day to day financial and accounting functions. He plays a strategic role in the company’s overall management, including shaping payor contracts, customer pricing strategies, broader business model decisions, and future M&A opportunities.\n\nPrior to joining Avalon in December of 2018, John served as CFO of California-based Medicare Advantage plan Alignment Healthcare, as well as of clinical laboratory services company Accumen. His other leadership roles have included EVP & COO at marketing services company Acxiom; EVP of Business Solutions at healthcare software company Eclipsys; and CFO of AT&T Business Services. John’s experience ranges from global, multi-billion-dollar businesses to start-up and young high-growth companies backed by private equity investors. Early in his career, John worked with EDS in various financial and operational roles for 15 years.\n\nJohn has a BA in economics from the University of Exeter (UK). He is a member of the Institute of Chartered Accountants.\n\nLynn Metter is Chief Technology Officer (CTO) at Avalon Healthcare Solutions and is responsible for the company’s technology strategy roadmap, partnering with Avalon’s product teams to deliver features and releases required for product development.\n\nLynn is a passionate software delivery executive with more than 25 years of experience building and leading agile teams that design and support complex software solutions. Since 2002, he has focused exclusively on technology that improves healthcare efficiency and delivery. Prior to joining Avalon, Lynn was CTO at DataLink Software, where he led the organization through significant platform improvements on the company’s value-based care solution for large payers and Management Services Organizations (MSOs). Lynn previously served as the Chief Delivery Officer of Ingenious Med and spent 16 years at Change Healthcare (formerly McKesson Corporation).\n\nLynn holds a BS in Computer Science from Columbus State University and an MBA from the University of Phoenix.\n\nSteve Morgan is General Counsel at Avalon Healthcare Solutions. An attorney with extensive healthcare regulatory, transactional, and management experience, Steve is responsible for all legal, compliance, and government affairs matters pertaining to the company.\n\nPrior to joining Avalon in 2015, Steve spent a decade with the nation’s largest pharmacy benefit manager, Express Scripts. Serving as Vice President and Associate General Counsel, Steve managed a team of attorneys and compliance officers supporting numerous Express Scripts businesses, including its PBM, government programs, Accredo Specialty Pharmacy, United BioSource Corporation, Freedom Fertility Pharmacy, and CuraScript SD Specialty Distribution. During Steve’s tenure at Express Scripts, the company grew from $16 billion to more than $100 billion in annual revenue. This growth was fueled in part by numerous acquisitions for which Steve provided legal support, including Express Scripts’ $29 billion acquisition of Medco Health Solutions.\n\nSteve previously worked for two Washington, D.C. law firms, where his legal practice focused on managed care organizations, healthcare providers, and pharmaceutical manufacturers.\n\nSteve received his BA with magna cum laude honors and a professional MBA from the University of Missouri. He received his JD with magna cum laude honors and MHA with distinction from St. Louis University.\n\nDr. Jason Bush is Executive Vice President, Product at Avalon Healthcare Solutions, where he is responsible for product strategy, design, and management.\n\nJason has more than 20 years of experience in leadership positions in venture capital-backed healthcare and life sciences companies. He joined Avalon in 2015 as the Senior Vice President of Clinical Operations and business owner for Avalon’s proprietary, best-in-class, flagship software, which automates the application of laboratory policies to health insurance claims. He was promoted to Chief Data Officer leading data analytics, advanced analytics, underwriting, business model analysis, and reporting services. Prior to that, Jason served as Vice President of Operations at AIT Laboratories (now HealthTrackRX), a commercial toxicology and forensic science laboratory, where he was integral in the company’s restructuring. As former Director of Clinical Operations for Precision Therapeutics (now Helomics, a Predictive Oncology Company), Jason led the laboratory through two years of 300 percent growth.\n\nJason received his Ph.D. in Chemical Engineering – Bioengineering from Carnegie Mellon University and an MBA from the University of Pittsburgh.\n\nAs Executive Vice President of Provider Networks for Avalon Healthcare Solutions, Mike Snyder manages laboratory networks that support high-quality, cost-effective laboratory services while promoting appropriate testing for patients.\n\nMike has more than 30 years of experience in the development of clinical laboratory strategies. Prior to joining Avalon, he was the Principal for Clinical Lab Business Solutions, a consulting firm that engages with laboratories to deliver collaborative solutions to health plans and employer groups. Mike has also served as Vice President of Laboratory Networks for UnitedHealthcare (UHC). In that capacity, he directed the company’s national strategy for laboratory services and participated in the development of its national provider network.\n\nPreviously, Mike served as Director of Business Development for Mount Sinai Hospital’s Center for Clinical Laboratories, where he saw outreach revenues triple following the implementation of a business plan that focused efforts on billing solutions and demonstrated the value of the medical center’s laboratory to attending faculty. Finally, Mike served as an executive with LabCorp (1980-2000), one of the largest commercial laboratories in the US.\n\nHe received his undergraduate degree at East Carolina University before commencing post-graduate studies at the University of North Carolina.\n\nDerek Anderson is Avalon’s Executive Vice President of Account Management. Derek is responsible for customer satisfaction through product and service delivery to Avalon’s clients.\n\nDerek comes to Avalon Healthcare Solutions with over 18 years of experience in the healthcare industry. Previous to joining the Avalon team, Derek worked at Cotiviti where he served as Vice President, Senior Client Engagement Lead, managing Cotiviti’s solutions for some of the largest health plans in the nation. Derek has worked with a spectrum of healthcare payers each with a variety of provider, member, and product profiles. Prior to his tenure in Client Engagement, Derek was a Director of Audit Operations within Cotiviti’s operations department. Throughout Derek’s years of healthcare experience working with both payers and providers, he has amassed an understanding of the healthcare industry across the payment continuum.\n\nDerek graduated from Northeastern University with a B.S. in Business Management and Entrepreneurship.\n\nMichele Norton has over 25 years’ experience in healthcare across many facets of the industry including payer, provider, ACO’s and life sciences organizations. She brings considerable experience and expertise in healthcare technology product, go to market strategy and marketing as well as optimization of clinical and analytics solutions and tech enabled services. Michele’s role includes defining the value and positioning, developing go to market strategies, and collaborating to create a strategic commercialization plan at scale for the Avalon portfolio of solutions. She is responsible for the full spectrum of marketing strategy and operations.\n\nPrior to joining Avalon, Michele was the Chief Product and Strategy Officer at MobileSmith Health which focused on mobile care technology for patients across PeriOp services and previous Chief Marketing and Product Officer at HealthMyne which focused on novel AI-enabled radiomic solutions for RWD and Life Sciences markets. In addition, she has held various senior executive positions at SCIO Health Analytics an EXL company, Zynx Health part of the Hearst Health family and McKesson Corporation. Her clinical and nursing informatics background provides her with a unique perspective on the impact data and technology can have on care quality and outcomes. She is passionate about helping clients translate insights into action, improve processes, drive engagement, measure outcomes and disseminate results.\n\nMichele received her Bachelor of Science in Nursing with high honors from the University of Florida and her Master of Science in Nursing with a healthcare informatics specialty from the University of Colorado Health Sciences Center. She has lectured and published nationally and internationally and is a member of several industry organizations.\n\nWendy Mudra is Vice President of Human Resources at Avalon Healthcare Solutions. In addition to being responsible for all tactical HR requirements at the company, she also plays a strategic role in staffing, organizational development, and creating a vibrant organizational culture.\n\nPrior to joining Avalon in 2015 as its first Human Resources employee, Wendy had 20 years of experience in the HR field, primarily with small to midsize companies. She was the Director of Human Resources at start-up specialty property and casualty insurance company Mount Beacon Insurance Company. She also held management positions at HCI and IFCO Systems. Early in her career, Wendy obtained generalist experience at Airem Capital and Uniroyal Optoelectronics.\n\nWendy holds a BA in Political Science from Wittenberg University. She is also PHR-certified through the Society for Human Resources Management.\n\nDr. Baird is the Chair of the Avalon Clinical Advisory Board. He is board-certified in Anatomic and Clinical Pathology as well as Clinical Chemistry. Dr. Baird serves as Professor and Chair of Laboratory Medicine and Pathology at the University of Washington in Seattle, WA. He is also the Director of Clinical Chemistry at Harborview Medical Center and Director of the UW Clinical Chemistry Fellowship Program.\n\nDr. Baird has served on numerous local and national committees, including the CMS/PAMA Clinical Diagnostic Laboratory Test Panel and ASCP’s Choosing Wisely Campaign Committee, where he has been instrumental in developing the ASCP’s Choosing Wisely recommendations. He is the recipient of the AACC’s Grannis Award for Excellence in Research and Scientific Publication and the International Federation of Clinical Chemistry’s Young Investigator award.\n\nDr. Baird is a member of the Academy of Clinical Laboratory Physicians and Scientists, the American Association for Clinical Chemistry, and the German Society of Clinical Chemistry and Laboratory Medicine. His clinical interests include rational laboratory test utilization, chemistry and toxicology, molecular diagnostics and proteomics.\n\nDr. Baird is a graduate of Stanford University, with a BS in Chemistry. He received his MD and PhD at the University of California, San Diego. He completed his residency in Anatomic and Clinical Pathology at the University of Washington in Seattle and a subspecialty fellowship training in molecular pathology and immunohistochemistry at PhenoPath Laboratories.\n\nDr. Timothy Hamill is the Prior Director of Clinical Laboratories at UCSF Medical Center’s China Basin and Parnassus campuses. In addition, he is Professor Emeritus and Ex-Vice Chair of the UCSF Department of Laboratory Medicine.\n\nDr. Hamill has held numerous memberships in UCSF Medical Center committees in his tenure, including the position of chair of the UCSF Medical Center Point of Care Testing Committee. He is also past chair of the California Department of Health Services Clinical Laboratory Technology Advisory Committee (CLTAC). He is currently President and member of the Board for the California Society of Pathologists, and a fellow of the American Society of Clinical Pathologists and College of American Pathologists.\n\nIn his career, Dr. Hamill has taken a lead in promoting laboratory science as a career and clinical laboratory scientist training as the Co-Chair of the Hospital Laboratory Workforce Initiative of the California Hospital Association. In addition, he has also been involved in developing better point-of-care testing practices through the College of American Pathologists as the Vice-Chair of the Point of Care Testing Resource Committee.\n\nDr. Hamill completed his medical degree from UC Davis’ School of Medicine. He was the chief resident in the departments of Laboratory Medicine at UCSF and San Francisco General Hospital. In addition, he completed a fellowship in Hematopathology at the Veterans Administration Medical Center in Martinez, CA. He is board-certified in clinical pathology and also hematopathology.\n\nDr. Gibson is Professor of Pathology and Chair, Department of Clinical Sciences and the Associate Dean for Faculty Affairs at the University of Central Florida College of Medicine. She teaches in the M.D. program, and practices at Nemours Children’s Health Orlando and Delaware.\n\nDr. Gibson is board certified by the American Board of Medical Genetics and Genomics (ABMGG), is a Founding Fellow of the American College of Medical Genetics (ACMG), and serves as a member of the American Board of Medical Genetics and Genomics Board of Directors, and the Association for Molecular Pathology Board of Directors. She served as a member of the Molecular Genetic Pathology Fellowship Milestones taskforce for the Accreditation Council for Graduate Medical Education (ACGME), and is a current member of the Test Development Committee for the American Board of Pathology. Dr. Gibson received her training at the University of Florida College of Medicine, and her practice includes molecular pathology and molecular genetics. She has served as the Director of Molecular Genetics for Orlando Health-M.D. Anderson Cancer Center Orlando, and later as the Director of Molecular Genetics and Cytogenetics for AmeriPath, Inc. (A Division of Quest Diagnostics).\n\nDr. Gibson is a graduate of the prestigious Hedwig van Amerigen Executive Leadership in Academic Medicine (ELAM) fellowship program. She is active in a number of national-level professional societies including the American College of Medical Genetics, the Association for Professors of Human and Medical Genetics, the Association for Molecular Pathology, and the Association of Pathology Chairs. She serves on editorial boards for the Journal of Molecular Diagnostics, and the Med Ed Portal Faculty Affairs Collection (AAMC). She has authored a number of book chapters, articles, and published abstracts in the fields of molecular pathology and genetics, and has been the principle investigator for numerous clinical trials.\n\nDr. Smith is Chair of the Department of Laboratory Medicine at the Yale School of Medicine and Professor of Laboratory Medicine, Biomedical Engineering, Internal Medicine and Pediatrics at Yale University. He is also the Chief of Laboratory Medicine at Yale New Haven Hospital.\n\nDr. Smith received his undergraduate degree from Princeton University, his medical degree from the Harvard Medical School, and his residency/fellowship training at The Brigham & Women’s Hospital, Boston Children’s Hospital, and Dana Farber Cancer Center. He is board certified in Pathology / Hematopathology and in Internal Medicine / Hematology-Oncology. He practices in all of his subspecialty areas. In addition to his clinical work, Dr. Smith has an investigative interest in the inflammation-coagulation interface, especially in relation to biomaterials, as well as in cellular immunotherapeutics, with over 175 publications. His educational activities include direction of an NIH-funded research training program in Immunohematology and Transfusion Medicine. He also lectures in the areas of biomedical ethics, “therapeutic pathology”, and in the education of the physician-scientist. Nationally, he has been member and chair for various NIH and American Heart Association research study sections, chair of the Association of Pathology Chairs Research Committee, and a member of the CDC Clinical Laboratory Integration into Healthcare Collaborative. He is the recipient of a number of Awards including Stohlman Scholar of the Leukemia & Lymphoma Society, National Blood Foundation Scholar, the Evans Award from the Academy of Clinical Laboratory Physicians and Scientists, and has served as a visiting professor at a number of universities.\n\nStephany Verstraete serves as the Chief Marketing & Engagement Officer at Teladoc Health Inc., responsible for all marketing, communications and consumer visit revenue for the global leader in whole person virtual care.\n\nA seasoned, high-growth leader who has held executive marketing roles spanning a breadth of industries in both public and private companies, Stephany has a proven record of building businesses and leading during periods of outstanding growth.\n\nWith a 20+ year record of successfully building brands and growing high-performing teams, she has held leadership roles at Match.com, Expedia, Hostess and PepsiCo. She was also a member of the founding team at a travel-based start-up.\n\nProficient in Spanish & French, Stephany holds an International Master of Business Administration from York University and an Honors Bachelor of Economics from Queen’s University in Canada.\n\nAs a Partner at Echo Health Ventures in Boston, Jessica A. Zeaske, PhD, MHS, MBA, identifies and invests in emerging and growth stage companies for Echo. She is a seasoned venture capitalist and board leader having worked at independent, corporate, and university funds, and has written dozens of investment themes over the years. She previously served as Director of Healthcare Investments at GE Ventures where she invested in precision health companies. Jessica came to GE Ventures from Lemhi Ventures, a fund investing in healthcare services with a focus on market disruption. Prior to joining Lemhi, Jessica worked on forming and spinning out MedTech and Life Science companies based on University intellectual property at U of Minnesota and Oregon Health & Science University. Jessica began her career writing software for a start-up healthcare delivery company. She then moved to a merchant bank, Greenspring Advisors, where they launched and invested in data-driven healthcare start-up companies.\n\nJessica received an undergraduate degree with honors from Stanford University, graduated from Johns Hopkins School of Public Health with a Master of Health Science and PhD, and completed her MBA with a focus on Healthcare Administration at Regis University. Jessica currently serves on the Boards of Avalon Healthcare Services, Genome Medical and Wildflower Health and is a Board Observer at Abacus Insights. Her previous Board of Director experience includes Apervita, Arcadia.io, PlanSource, OneHealth, PokitDok, Orasi Medical, Medication Management Solutions, plus significant work at Bind On-Demand Health Insurance. Jessica also serves on the Board of DentaQuest Partnership for Oral Health Advancement, is a Trustee for Boston Medical Center’s Exceptional Care Without Exception Trust, is an Advisory Board member for Boston Children’s Hospital, and is a member of the National Association of Corporate Directors.\n\nAndy Folsom joined BlueCross BlueShield of South Carolina (BCBSSC) in Columbia, SC in 2009. He currently serves as President of Companion Life Insurance Company, a wholly owned subsidiary of BCBSSC. Prior to Companion Life, Andy served as Vice President of M&A, Strategic Investments and Tax for BCBSSC. Andy also worked in the Law Department as AVP and Deputy General Counsel when first joining BCBSSC. Before joining BCBSSC, Andy worked as a corporate transactional attorney at Alston & Bird in Atlanta, GA. Andy holds a BA from Washington and Lee University and a JD from the University of South Carolina School of Law.\n\nIn addition to his role at Companion Life, Andy currently serves as a Board member at the Salute from the Shore, Transitions Homeless Center and Central Carolina Community Foundations.\n\nDr. Pratt is a Medical and Clinical Molecular Geneticist board-certified by the American College of Medical Genetics. She is the Director of the Pharmacogenomics Laboratory at Indiana University School of Medicine. Prior to joining Indiana University, she was Chief Director, Molecular Genetics, for Quest Diagnostics Nichols Institute.\n\nIn addition to her work, Dr. Pratt is currently serving on the Centers for Medicare and Medicaid Services Clinical Diagnostic Laboratory Tests Advisory Panel. Dr. Pratt continues to serve on the CDC’s GeT-RM program for reference materials for Molecular Genetics. She is currently serving on the Institute of Medicine/National Academy of Medicine’s Roundtable on Translating Genomic-Based Research for Health and Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies. She also served on the U.S. Secretary of Health and Human Services Advisory Committee on Genetics, Health and Society for the Oversight of Genetic Testing and the Advisory Committee on Hereditary Disorders in Newborns and Children. She also participated in the preparation of the Morbidity and Mortality Weekly Report for Best Practices in Molecular Genetic Testing for the Centers for Disease Control and Prevention (CDC).\n\nDr. Pratt is Past Chair of the Clinical Practice Committee and is currently a member of the Professional Relations committee, and is the chair of the Program committee for the Association of Molecular Pathology. She is a former advisor of EurogenTest for genetic test validation. Dr. Pratt serves on the American Medical Association’s (AMA’s) Molecular Pathology Current Procedural Terminology (CPT) Advisory committee.\n\nDr. Pratt has authored over 50 peer-reviewed manuscripts and book chapters. She is also an Associate Editor for the Journal of Molecular Pathology.\n\nDr. Pratt graduated with a Ph.D. in Medical and Molecular Genetics from Indiana University School of Medicine, Indianapolis, IN in 1994. Her fellowship training was in Ph.D. Medical and Clinical Molecular Genetics at Henry Ford Hospital, Detroit MI.\n\nDavid is a special advisor to the CEO of the University of Rochester (U of R) Medical Center, a professor of public health sciences in the U of R School of Medicine and Dentistry and an executive professor of health care management in the U of R William E. Simon Graduate School of Business (Simon School).\n\nDavid was CEO of The Lifetime Healthcare Companies (TLHC) in Rochester, NY which includes Excellus BlueCross BlueShield, Univera Healthcare, Lifetime Health Medical Group, Lifetime Care, EBS-RMSCO Benefit Solutions and MedAmerica.\n\nDavid serves as chair and director of the New York eHealth Collaborative overseeing the state’s Health Information Technology initiatives."
    }
}